Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Correlation between adiponectin and reduction of cell adhesion molecules after pitavastatin treatment in hyperlipidemic patients with type 2 diabetes mellitus
Shosaku� Nomura, Akira Shouzu, Seitarou Omoto, et al.
Thrombosis Research (2007) Vol. 122, Iss. 1, pp. 39-45
Closed Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

The effects of pitavastatin, eicosapentaenoic acid and combined therapy on platelet-derived microparticles and adiponectin in hyperlipidemic, diabetic patients
Shosaku� Nomura, Norihito Inami, Akira Shouzu, et al.
Platelets (2009) Vol. 20, Iss. 1, pp. 16-22
Closed Access | Times Cited: 101
Fluvastatin for lowering lipids
Stephen P. Adams, Sarpreet S Sekhon, Michael Tsang, et al.
Cochrane library (2018) Vol. 2018, Iss. 3
Open Access | Times Cited: 65
Impact of pitavastatin on new-onset diabetes mellitus compared to atorvastatin and rosuvastatin: a distributed network analysis of 10 real-world databases
Won‐Woo Seo, Seung In Seo, Yerim Kim, et al.
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 38
Dynamic Role of Microparticles in Type 2 Diabetes Mellitus
Shosaku� Nomura
Current Diabetes Reviews (2009) Vol. 5, Iss. 4, pp. 245-251
Closed Access | Times Cited: 76
Relationship between circulating levels of RANTES (regulated on activation, normal T-cell expressed, and secreted) and carotid plaque characteristics: the Atherosclerosis Risk in Communities (ARIC) Carotid MRI Study
Salim S. Virani, Vijay Nambi, Ron C. Hoogeveen, et al.
European Heart Journal (2010) Vol. 32, Iss. 4, pp. 459-468
Open Access | Times Cited: 59
CD40–CD40L: Linking pancreatic, adipose tissue and vascular inflammation in type 2 diabetes and its complications
Tom Seijkens, Pascal Kusters, David Engel, et al.
Diabetes and Vascular Disease Research (2012) Vol. 10, Iss. 2, pp. 115-122
Open Access | Times Cited: 53
Could changes in adiponectin drive the effect of statins on the risk of new-onset diabetes? The case of pitavastatin
Lorenzo Arnaboldi, Alberto Corsini
Atherosclerosis Supplements (2015) Vol. 16, pp. 1-27
Closed Access | Times Cited: 48
Pitavastatin for lowering lipids
Stephen P. Adams, Nima Alaeiilkhchi, James M Wright
Cochrane library (2020) Vol. 2020, Iss. 7
Open Access | Times Cited: 33
Comparison of effects of pitavastatin and atorvastatin on glucose metabolism in type 2 diabetic patients with hypercholesterolemia
Tomoya Mita, Shiho Nakayama, Hiroko Abe, et al.
Journal of Diabetes Investigation (2013) Vol. 4, Iss. 3, pp. 297-303
Open Access | Times Cited: 37
Pitavastatin: A Review in Hypercholesterolemia
Sheridan M. Hoy
American Journal of Cardiovascular Drugs (2017) Vol. 17, Iss. 2, pp. 157-168
Closed Access | Times Cited: 34
The place of original pitavastatin in primary and secondary prevention of cardiovascular diseases. Interdisciplinary Expert Consensus of the Russian Society of Cardiology, the National Atherosclerosis Society, the Russian Society of Cardiosomatic Rehabilitation and Secondary Prevention, and the Russian Association of Endocrinologists
М. Г. Бубнова, А. S. Galyavich, М. В. Ежов, et al.
Cardiosomatics (2025)
Open Access
Effect of acarbose on platelet-derived microparticles, soluble selectins, and adiponectin in diabetic patients
Takayuki Shimazu, Norihito Inami, Daisuke Satoh, et al.
Journal of Thrombosis and Thrombolysis (2009) Vol. 28, Iss. 4, pp. 429-435
Closed Access | Times Cited: 43
Beneficial direct adipotropic actions of pitavastatin in vitro and their manifestations in obese mice
Yasuhiro Ishihara, Koji Ohmori, Mizuki Mizukawa, et al.
Atherosclerosis (2010) Vol. 212, Iss. 1, pp. 131-138
Closed Access | Times Cited: 39
Hyperlipidemia and Hyperinsulinemia in the Spontaneous Osteoarthritis Mouse Model, STR/Ort
Kentaro Uchida, Ken Urabe, Kouji Naruse, et al.
EXPERIMENTAL ANIMALS (2009) Vol. 58, Iss. 2, pp. 181-187
Open Access | Times Cited: 37
Effects of miglitol in platelet-derived microparticle, adiponectin, and selectin level in patients with type 2 diabetes mellitus
Shosaku� Nomura, Omoto, Yokoi, et al.
International Journal of General Medicine (2011), pp. 539-539
Open Access | Times Cited: 31
Is statin‐induced diabetes clinically relevant? A comprehensive review of the literature
David S.H. Bell, James J. DiNicolantonio, James H. O’Keefe
Diabetes Obesity and Metabolism (2013) Vol. 16, Iss. 8, pp. 689-694
Closed Access | Times Cited: 29
Impact of pitavastatin on high-sensitivity C-reactive protein and adiponectin in hypercholesterolemic patients with the metabolic syndrome: The PREMIUM Study
Tatsuaki Matsubara, Keiko Naruse, Takemi Arakawa, et al.
Journal of Cardiology (2012) Vol. 60, Iss. 5, pp. 389-394
Closed Access | Times Cited: 29
Place of pitavastatin in the statin armamentarium: promising evidence for a role in diabetes mellitus
Kouji Kajinami, Kawai Yasusyuki
Drug Design Development and Therapy (2011), pp. 283-283
Open Access | Times Cited: 28
Systematic Review and Meta-Analysis of the Effect of Statins on Circulating E-Selectin, L-Selectin, and P-Selectin
Angelo Zinellu, Arduino A. Mangoni
Biomedicines (2021) Vol. 9, Iss. 11, pp. 1707-1707
Open Access | Times Cited: 18
Effects of pitavastatin on monocyte chemoattractant protein-1 in hyperlipidemic patients
Shosaku� Nomura, Akira Shouzu, Seitarou Omoto, et al.
Blood Coagulation & Fibrinolysis (2009) Vol. 20, Iss. 6, pp. 440-447
Closed Access | Times Cited: 26
Obesity in Prediabetic Patients: Management of Metabolic Complications and Strategies for Prevention of Overt Diabetes
Marco Chianelli, Marina Armellini, Maria Carpentieri, et al.
Endocrine Metabolic & Immune Disorders - Drug Targets (2024) Vol. 25, Iss. 1, pp. 8-36
Open Access | Times Cited: 2
Effect of GLP-1RA Treatment on Adhesion Molecules and Monocyte Chemoattractant Protein-1 in Diabetic Patients with Atherosclerosis
Marcin Hachuła, Marcin Basiak, Michał Kosowski, et al.
Life (2024) Vol. 14, Iss. 6, pp. 690-690
Open Access | Times Cited: 2
Anti-atherosclerotic effects of sitagliptin in patients with type 2 diabetes mellitus
Shosaku� Nomura, Seitaro Omoto, Takehito Taniura, et al.
Diabetes Metabolic Syndrome and Obesity (2015), pp. 339-339
Open Access | Times Cited: 16
Effects of teneligliptin on PDMPs and PAI-1 in patients with diabetes on hemodialysis
Shosaku� Nomura, Y Okuda, Seitaro Omoto, et al.
International Journal of General Medicine (2016), pp. 65-65
Open Access | Times Cited: 15
Clinical Benefits of Pitavastatin: Focus On Patients With Diabetes Or at Risk of Developing Diabetes
Vivencio Barrios, Carlos Escobar
Future Cardiology (2016) Vol. 12, Iss. 4, pp. 449-466
Closed Access | Times Cited: 14
Page 1 - Next Page

Scroll to top